Nmn And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of Parkinsonism
Patent No. EP4079311 (titled "Nmn And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of Parkinsonism") was filed by Nuvamid on Apr 20, 2021. The application was issued on Oct 1, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4079311
- Application Number
- EP21169363A
- Filing Date
- Apr 20, 2021
- Status
- Granted And Under Opposition
- Aug 29, 2025
- Publication Date
- Oct 1, 2025
- External Links
- Slate, Register , Google Patents